Telzuit Medical Technologies, Inc. Investment Profile Issued by Beacon Equity Research.

DALLAS -- Beacon Equity Research has issued a new investment profile on Telzuit Medical Technologies, Inc. (OTCBB: TZMT) which outlines the firm's business model, products, and market opportunities. The report is authored by Senior Research Analyst, Shailesh Dhuri, CFA.

The full report is available at: http://www.beaconequityresearch.com or http://www.telzuit.com/assets/pdf/finalbeacon.pdf.

In the report Mr. Dhuri writes, "The Company operates in the medical devices industry, which is dominated by companies such as Meditronic (NYSE: MDT), Zimmer Holding (NYSE: ZMH), St Jude Medical (NYSE: STJ), Biomet (Nasdaq: BMET), and Smith & Nephew (NYSE: SNN)."

"The Company has developed the STATPATCH Wireless Heart Monitor, an ambulatory medical device which monitors, measures and records physiological signals generated by the body. The Company has received FDA approval for two of its products, the Patch Wireless Holter Monitor and the Patch Wireless Event Monitor. The STATPATCH Wireless Holter Monitor has commenced production and is expected to be on the market by the fourth quarter of CYO6."

Beacon Equity Research Disclosure

The analysts contributing to this report do not hold any shares of Telzuit Medical Technologies, Inc. (TZMT). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Research has been directly compensated eighteen thousand dollars for the creation of this research report by TZMT. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.

Anyone interested in receiving alerts regarding Telzuit Medical Technologies, Inc. research should email [e-mail] with "TZMT" in the subject line.